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Summary 
Defects of the ANF System in cirrhosis could not be demonstrated in terms of an ab-
solute deficiency of plasma levels or evidently major abnormalities of processing in 
patients with cirrhosis. In the present study the responsiveness of the ANF System to 
acute volume Stimulation by water immersion, the diuretic and natriuretic effects of 
ANF infusion were examined. Stimulation of ANF release by 1 h immersion was signi-
ficantly blunted in 10 cirrhotic patients with ascites (increase of plasma ANF by 46 ± 
18%), whereas 11 cirrhotics without ascites showed a 104 ± 16% increase, similar to the 
117 ± 29% Stimulation in 25 healthy controls. Immersion increased urinary volume by 
3.6 ± 0.6, 2.0 ± 0.8, and 0.7 ± 0.4 ml/min, and urinary sodium excretion by 146 ± 38, 
75 ± 43, and 43 ± 19 |imol/min in controls, cirrhotics without ascites, and cirrhotics 
with ascites, respectively. Infusion of ANF for 30 min prompted an increase in diuresis 
and natriuresis in seven cirrhotic patients, which was less marked in patients with ascites 
as compared to patients without. Thus, the stimulus-response coupling for ANF may be 
impaired in patients with cirrhosis and ascites. 
Introduction 
The pathophysiology of renal sodium retention and ascites formation in patients with 
cirrhosis of the liver has become rather perplexing. There is increasing evidence that 
activation of the renin-aldosterone System is just one of several factors involved in the 
impaired volume regulation of cirrhosis. For many years, a deficiency of a putative 
natriuretic hormone in cirrhosis has been postulated, but never satisfactorily demon-
strated. Therefore, investigations on the role of the novel atrial natriuretic factor (ANF) 
(7) in cirrhosis have been anticipated. 
The first communication on ANF plasma levels in cirrhosis showed that there is no 
absolute deficiency of this novel natriuretic and diuretic hormone in patients with 
cirrhosis (9). These findings have been confirmed by several groups, reporting ANF 
plasma levels in patients with cirrhosis and ascites equal to or higher than normal (11). 
However, the immunoreactive ANF in plasma of patients with cirrhosis might include 
different molecular species with altered biological activity, as has been suggested in 
patients with congestive heart failure (3). By high Performance gel permeation chromato-
graphy only negligible amounts of immunoreactivity coeluting with precursor forms of 
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ANF 99-126 have been detected (2). Thus, no evidence for major abnormalities of proces-
sing of ANF was found in cirrhosis. 
Neither basal plasma levels nor characterization of immunoreactivity necessarily reflect 
the functional Status or the compensatory reactivity of the ANF System. Therefore, in the 
present study responsiveness of the ANF System to volume Stimulation was investiga-
ted. Head out of water immersion (WI) in a thermoneutral bath has been shown to induce 
central hypervolemia with atrial distention and to prompt natriuresis and diuresis (4). 
Epstein and others have demonstrated in numerous investigations that WI is a useful tool 
for the study of volume regulation (5): it increases central volume by shifting blood from 
peripheral vessels thus obviating the necessity of infusing volume expanders that might 
alter plasma composition. We demonstrated that WI rapidly increases ANF plasma levels 
in healthy human subjects (10). In the present study WI was used to investigate the 
response of ANF to acute volume Stimulation in patients with cirrhosis. 
Infusion of ANF has been shown to induce diuresis and natriuresis in healthy subjects 
(15). The initial Observation of a diuretic effect of ANF in a patient with cirrhosis and 
refractory ascites (8) prompted us to investigate the renal response to ANF infusion in 
cirrhotic patients. 
Patients and methods 
Water immersion: 25 healthy controls and 21 patients with cirrhosis, 10 with ascites and 
11 without ascites were investigated after informed consent had been obtained. There was 
no evidence for cardiovascular, renal, or pulmonary disease in control or patients. No 
diuretics had been given to any subject for one week preceeding the study. Subjects were 
on a hospital diet containing approximately 150 meq sodium/day and were prohibited 
alcohol, tobacco, tea, and coffee the day before and during the experiment. In the moming 
after complete emptying of the bladder, a catheter was placed in a forearm vein, subjects 
were given 400 ml of water orally and were seated next to a tank with thermoneutral 
(34.5 ± 0.2*C) water. After 1 h the subjects were immersed up to their necks in the water 
bath, maintaining the same position for 1 h. This was followed by another hour of 
sitting outside the tank. Throughout the investigation 200 ml/hour of water were given 
orally to ensure adequate urine flow. Urine obtained by spontaneous emptying of the 
bladder was collected before (0), after 60 min (60 min) and 60 min subsequent to (120 
min) the end of immersion. Blood samples were obtained at 0.60 and 120 min. 
ANF infusion: ANF (Bissendorf, West Germany) was infused (50ng/kg/min) into a 
forearm vein of seven patients with cirrhosis, three without and four with ascites in the 
supine position, (the patients bladder were emptied lh before starting the infusion) urine 
was collected immediately before, 1 and 2 h after the Start of the infusion. Plasma 
samples were collected before, 30 min and 2 h after Start of the infusion. ANF was deter-
mined in extracted plasma samples as described before (2). Plasma renin activity was 
measured by RIA (16). Data are given as mean and Standard error. Data were evaluated 
statistically by paired or unpaired Students Mest. 
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Fig. 1. Plasma levels of Atrial Natriuretic Factor, urinary volume and urinary sodium 
excretion before (0 min), after 1 hour (60 min) and 1 hour subsequent to (120 min) the end 
of water immersion in 25 healthy controls, 11 cirrhotic patients without and 10 cirrhotic 
patients with ascites. * p < 0.05, ** p < 0.01 as compared to baseline levels 
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Results 
Volume Stimulation by water immersion caused a rise of plasma ANF from 6.0 ± 0.6 
to 13.6 ± 2.6 fmol/ml in healthy subjects and from 8.5 ± 1.3 to 16.5 ± 2.6 fmol/ml in 
cirrhotic patients without ascites; increases were significant at the p < 0.01 level. In cirr-
hotics with ascites Stimulation of ANF from 7.7 ± 1.3 to 11.4 ± 2.3 fmol/ml was 
significantly (p < 0.05) blunted as compared to cirrhotics without ascites (Fig. 1). 
The renal response to immersion is illustrated in Fig. 1. Mean increases in urinary 
volume were found to be 3.64 ± 0.60 ml/min in controls, 2.02 ± 0.81 ml/min in 
cirrhotics without ascites, and only 0.68 ± 0.35 ml/min (not significantly different from 
baseline values) in cirrhotics with ascites. Similar differences were observed in urinary 
sodium excretion: immersion induced a rise by 146 ± 38 |imol/min in controls, by 75 ± 
43 jxmol/min in cirrhotics without ascites, and by only 43 ± 19 |imol/min in cirrhotics 
with ascites. Increases in both cirrhotic groups did not reach the level of significance. 
Fig. 2 . Increase of diuresis and natriuresis 1 hour after the beginning of a 30 minute 
infusion of ANF and suppression of plasma renin activity after 30 minutes of infusion in 3 
cirrhotic patients without and 4 cirrhotic patients with ascites 
Infusion of ANF markedly stimulated diuresis and natriuresis in the hour subsequent to 
the beginning of the infusion. After another hour renal parameters returned to baseline 
levels. In patients without ascites the effects were stronger than in patients with ascites 
(Fig. 2): urinary volume increased by 6.8 ± 3.6 as compared to 1.8 ± 0.3 ml/min, 
sodium excretion increased by 195 ± 93 as compared to 105 ± 19 |imol/min. Plasma 
renin activity in patients without ascites decreased from 13 ± 11 to 7 ± 5 ng Al/ml/h; 
and a similar suppression from 27 ± 21 to 16 ± 10 ng Al/ml/h was seen in patients with 
ascites. 
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Discussion 
The Observation that water immersion significantly increases ANF plasma levels in a 
large number of healthy subjects is in accordance with previous results from our labo-
ratory (10) and has been confirmed by other investigations (1,6,13,14). Similar increases 
were observed in patients with cirrhosis of the liver without ascites. In cirrhotics with 
ascites, however, Stimulation of ANF release into the plasma was found to be signifi-
cantly reduced after 1 h of immersion. This might be due to a decreased volume Stimulus 
in these patients. However, plasma renin activity as an indicator of centrally effective 
volume decreased in cirrhotics with ascites by a ratio not different from that in cirrhotics 
without ascites or controls (unpublished observations). Furthermore, central hemodyna-
mics and intracardiac pressures are influenced by water immersion independent of the 
degree of ascites (12). Thus, a blunted increase of atrial pressure as a Stimulus for ANF 
release does not seem a likely explanation for the observed blunted ANF Stimulation in 
these patients. Therefore, a defective ANF synthesis or release might be suspected in 
these patients. 
The blunted ANF Stimulation was paralleled by reduced increases of urinary sodium 
excretion and urinary volume following immersion in cirrhotics with ascites. While this 
might suggest a (patho-)physiological role of ANF in volume regulation, no correla-
tions of either basal or stimulated ANF with renal response could be found. In view of 
the involvement of several other hormonal Systems in volume regulation, however, this 
finding is not surprising. 
Furthermore, at comparable baseline plasma levels of ANF, excretion of sodium was 
diminished in cirrhotic patients as compared to controls, and in patients with ascites as 
compared to patients without ascites. The renal response to Stimulation by water immer-
sion was less marked than the increase of ANF in the cirrhotic groups. These findings 
might be consistent with the increased activitiy of sodium retaining principles, counter-
acting the renal action of ANF, or blunted responsiveness of the kidney to ANF in cir-
rhosis. 
Infusion of ANF at a rather low dose induced a marked diuresis and natriuresis in 
patients with cirrhosis, with a less marked response of the patients with ascites. This 
might have been due to the lowering of systematic blood pressure by ANF, causing a 
reflectory increase of renin activity, counteracting the renal effects of ANF. However, 
with the dose applied no marked decreases of blood pressure were seen and plasma renin 
activity was suppressed in both cirrhotic groups. Thus, a reduced activity of the renal 
receptor-effector coupling must be taken into consideration in patients with decompen-
sated cirrhosis. 
This study demonstrates a blunted response of ANF release to water immersion in 
patients with cirrhosis of the liver and might indicate a reduced renal response to ANF in 
patients with ascites, thus, suggesüng a role for this novel hormone in the impairment 
of acute volume regulation in cirrhosis. 
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